Steven Yakubov, MD
Interventional Cardiology · Columbus, OHNPI 1316942782
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Medtronic at 45.8% of the total. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,661 payments — averaging $545.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$415K
- Johnson & Johnson$141K
- Boston Scientific$135K
- Atricure, Inc.$61K
- Anika Therapeutics, Inc.$51K
- ZOLL Circulation Inc$34K
- plus $70K from 28 others
Across 332 payments — averaging $7244.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$1.3M
- Medtronic$980K
- Edwards Lifesciences$105K
- Livanova USA, Inc.$26K
- Atricure, Inc.$5K
- Abbott$5K
- plus $1K from 1 others
What the payments were for
- Consulting fees$267,74130%
- Speaking & faculty fees$453,04650%
- Grants$13,8562%
- Travel & lodging$72,4508%
- Food & beverage$48,0575%
- Education$1200%
- Entertainment$2950%
- Ownership interest$41,2025%
- Other$9,7531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 1,086 | $415,150 |
| Johnson & Johnson | 106 | $140,820 |
| Boston Scientific | 162 | $134,587 |
| Atricure, Inc. | 16 | $61,339 |
| Anika Therapeutics, Inc. | 4 | $50,673 |
| ZOLL Circulation Inc | 29 | $33,517 |
| Amplitude Vascular Systems, Inc. | 2 | $17,259 |
| Occlutech US LLC | 1 | $12,000 |
| Biotronik Inc. | 86 | $10,863 |
| Abbott | 57 | $8,115 |
| Edwards Lifesciences | 46 | $4,609 |
| Regeneron Healthcare Solutions, Inc. | 12 | $4,533 |
| Sanofi-aventis U.S. LLC | 3 | $3,401 |
| Pfizer | 2 | $2,645 |
| Biosense Webster, Inc. | 2 | $1,350 |
| Medicure Pharma Inc. | 4 | $1,300 |
| Shockwave Medical, Inc | 8 | $714 |
| Siemens Medical Solutions USA, Inc. | 3 | $543 |
| Jenavalve Technology, Inc. | 4 | $474 |
| Recor Medical Inc | 1 | $450 |
| AbbVie | 4 | $341 |
| Itamar Medical Inc | 1 | $295 |
| E.r. Squibb & Sons, L.L.C. | 2 | $267 |
| Merit Medical Systems Inc | 1 | $200 |
| Livanova USA, Inc. | 6 | $184 |
| W. L. Gore & Associates, Inc. | 1 | $163 |
| Cardiovascular Systems Inc. | 2 | $161 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $141 |
| Philips North America LLC | 3 | $131 |
| Opsens Inc. | 2 | $94 |
| AstraZeneca | 1 | $90 |
| Abiomed | 1 | $90 |
| Cardinal Health 200 LLC | 1 | $11 |
| Croivalve Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$249,873
- XARELTO$138,945
- CoreValve Evolut$87,878
- LARIAT SUTURE DELIVERY DEVICE$60,000
- TherOx DS2 Console$33,421
- Catheter$33,421
- Downstream Cartridge$33,421
- GENERAL - THERAPIES$20,124
- GENERAL - STRUCTURAL HEART$18,592
- GENERAL VASCULAR ACCESS$15,652
- Resolute$14,917
- PRALUENT$7,610
- NAVITOR$3,122
- ELIQUIS$2,875
- Sentinel$1,875
- Endurant$1,555
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,483
- Carto 3$1,350
- PK Papyrus$1,335
- Orsiro$1,305
How this compares
$906,520 in reported general payments places this provider in the 95th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 51 | $50,121 |
| XareltoRivaroxaban | 20 | $18,868 |
| Atorvastatin Calcium | 256 | $2,380 |
| Ranolazine ErRanolazine | 20 | $2,357 |
| ClopidogrelClopidogrel Bisulfate | 164 | $1,444 |
| Metoprolol Succinate | 140 | $1,243 |
| Losartan Potassium | 155 | $795 |
| Rosuvastatin Calcium | 71 | $643 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 55 | $632 |
| Amlodipine Besylate | 79 | $345 |
| Metoprolol Tartrate | 47 | $288 |
| Nitroglycerin | 29 | $260 |
| Spironolactone | 14 | $149 |
| Carvedilol | 24 | $135 |
| Pantoprazole Sodium | 12 | $127 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $2,645 | $50,12151 claims |
| Johnson & JohnsonXarelto | $140,820 | $18,86820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 256 interventional cardiology providers in Ohio.
Other interventional cardiology in Columbus
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- Michael JollyColumbus$281K
- Timothy SmithColumbus$149K
- Christopher HuffColumbus$119K
- Joseph CampbellColumbus$114K
- Aref AmroColumbus$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.